Some patients want to take a holiday pause on diabetes or weight-loss drugs. Here’s what doctors say they need to know
Around the holidays – when many people are baking cookies for Santa, enjoying cocktail parties or having festive family feasts – some adults who use popular medications for diabetes or weight loss ...
Bye-bye BBLs: How Y2K fashion and Ozempic created a new class divide
PERSPECTIVES: The resurgence of Y2K skin-baring fashion trends coincides with the rise of prescription weight loss drugs like ...
Zepbound and Mounjaro are the two best-in-class products right now, says Dr. Scot Gottlieb
Former FDA Commissioner Dr. Scot Gottlieb joins 'Squawk Box' to discuss the future of pharmaceutical advertising, health care ...
The Week47m
What went wrong with Novo Nordisk’s CagriSema obesity drug trial
The drug helped patients reduce their weight by only 22.7 per cent, falling short of the anticipated result. Novo’s shares ...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
Hot Obesity Drug Market Will Keep Investors Gripped Next Year
Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug ...